epstein-barr virus nuclear antigen 2 transactivates latent membrane protein lmp1.

NLM AIDSLINE Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. Wang F; Tsang SF; Kurilla MG; Cohen JI; Kieff E; Department of Medicine,
September 30, 1990

J Virol. 1990 Jul;64(7):3407-16. Unique Identifier : AIDSLINE Several lines of evidence are compatible with the hypothesis that Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA-2) or leader protein (EBNA-LP) affects expression of the EBV latent infection membrane protein LMP1. We now demonstrate the following. (i) Acute transfection and expression of EBNA-2 under control of simian virus 40 or Moloney murine leukemia virus promoters resulted in increased LMP1 expression in P3HR-1-infected Burkitt's lymphoma cells and the P3HR-1 or Daudi cell line. (ii) Transfection and expression of EBNA-LP alone had no effect on LMP1 expression and did not act synergistically with EBNA-2 to affect LMP1 expression. (iii) LMP1 expression in Daudi and P3HR-1-infected cells was controlled at the mRNA level, and EBNA-2 expression in Daudi cells increased LMP1 mRNA. (iv) No other EBV genes were required for EBNA-2 transactivation of LMP1 since cotransfection of recombinant EBNA-2 expression vectors and genomic LMP1 DNA fragments enhanced LMP1 expression in the EBV-negative B-lymphoma cell lines BJAB, Louckes, and BL30. (v) An EBNA-2-responsive element was found within the -512 to +40 LMP1 DNA since this DNA linked to a chloramphenicol acetyltransferase reporter gene was transactivated by cotransfection with an EBNA-2 expression vector. (vi) The EBV type 2 EBNA-2 transactivated LMP1 as well as the EBV type 1 EBNA-2. (vii) Two deletions within the EBNA-2 gene which rendered EBV transformation incompetent did not transactivate LMP1, whereas a transformation-competent EBNA-2 deletion mutant did transactivate LMP1. LMP1 is a potent effector of B-lymphocyte activation and can act synergistically with EBNA-2 to induce cellular CD23 gene expression. Thus, EBNA-2 transactivation of LMP1 amplifies the biological impact of EBNA-2 and underscores its central role in EBV-induced growth transformation. Antigens, Viral/GENETICS/PHYSIOLOGY B-Lymphocytes/PHYSIOLOGY Blotting, Western Cell Division Cell Transformation, Viral Cloning, Molecular Gene Expression Regulation, Viral Genes, Structural, Viral Human In Vitro Regulatory Sequences, Nucleic Acid Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. Trans-Activators/*PHYSIOLOGY JOURNAL ARTICLE

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Photographs from A Day with HIV Now Online Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 ARIZONA: Routine Skin Testing Available Again at Tuberculosis Clinic Starting May 20 NORTH DAKOTA: Officials: 26 Tuberculosis Cases from Grand Forks Outbreak AUSTRALIA: HIV Rates Triple in the Northern Territory in Just 12 Months ARIZONA: Parsons Foundation Gives $3 Million to Southwest Center for HIV/AIDS UNITED STATES: Triple Therapy for Hepatitis C is Effective After Liver Transplantation, but Side-Effects Are Common CANADA: Nunavut Uses Comic Book to Do Sex Education NEW HAMPSHIRE: State Health Officials Urge Hepatitis Testing UNITED STATES: Hepatitis C Testing for People Born Between 1945 and 1965 People with HIV pay more for life insurance – if they can get it (South Africa)Uganda: Gov't Urged to Levy a Tax On Alcohol to Fund HIV More than 60 dental patients test positive for viruses MASSACHUSETTS: Mass. Looks Into Risk of Virus at BMC INTERNATIONAL: Hepatitis C Virus Carriers Need Sufficient Vitamin A Discovery Could Lead to New Drugs to Block Deadly Viruses Einige HIV-Positive haben Virus auch nach Ende von Therapie im Griff - Studie: Virenzahl auch nach sieben Jahren ohne Medizin gering AUSTRALIA: Study Finds Protein Link to Sexually Transmitted Disease Susceptibility Analysis: Emerging deadly virus demands swift sleuth work The Hutchinson Santé G-VIR® Glove Reduces the Risk of HIV Virus Transmission in Accidental Needlesticks by 99%, According to a Study Published in the Journal Surgery in February 2013[1]Protein blocks HIV, other deadly viruses UNITED STATES: HIV/AIDS Study - Link to Rapid Advancement of HIV Virus Found in Semen: NIH
Information in this article was accurate in September 30, 1990. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.